SBIR-STTR Award

Enzymatic Luminescence microRNA Assay
Award last edited on: 7/2/12

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$960,166
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Ye Sun

Company Information

Aurogene Life Science (AKA: Sci-Tec Inc)

156 Fairbanks Road
Oak Ridge, TN 37830
   (865) 275-5800
   sales@aurogene.com
   www.aurogene.com
Location: Single
Congr. District: 03
County: Anderson

Phase I

Contract Number: 1R43CA126647-01
Start Date: 5/1/07    Completed: 4/30/09
Phase I year
2007
Phase I Amount
$100,000
The goal of this project is to develop a new, highly sensitive, and cost-effective RNA Enzymatic Luminescence Assay (qELA) for high-throughput detection and quantification of microRNA in biological samples. The assay implements the same detection concept known from pyrosequencing, yet expands pyrosequencing detection methodology for highly sensitive and accurate quantification of small RNA molecules. The proposed assay has unique sensitivity and dynamic range and is expected to outperform real-time PCR in applications for analysis of small RNA molecules. The qELA requires less expensive reagents and equipment than RT-PCR and microarrays and can be used in a number of commercial assays for application in life sciences research, drug discovery, and clinical diagnosis.

Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.

Phase II

Contract Number: 5R43CA126647-02
Start Date: 5/1/07    Completed: 4/30/09
Phase II year
2008
(last award dollars: 2011)
Phase II Amount
$860,166

The goal of this project is to develop a new, highly sensitive, and cost-effective RNA Enzymatic Luminescence Assay (qELA) for high-throughput detection and quantification of microRNA in biological samples. The assay implements the same detection concept known from pyrosequencing, yet expands pyrosequencing detection methodology for highly sensitive and accurate quantification of small RNA molecules. The proposed assay has unique sensitivity and dynamic range and is expected to outperform real-time PCR in applications for analysis of small RNA molecules. The qELA requires less expensive reagents and equipment than RT-PCR and microarrays and can be used in a number of commercial assays for application in life sciences research, drug discovery, and clinical diagnosis.

Public Health Relevance:
This Public Health Relevance is not available.

Thesaurus Terms:
Luminescence, Microrna Dna, Rna, Art, Base, Bioluminescence, Biomedical Facility, Clinical Research, Concept, Copying, Diagnosis, Drug Discovery /Isolation, Electromagnetic Radiation, Family, Fasting, High Throughput Technology, Lead, Lighting, Luciferin, Neoplasm /Cancer, Nucleic Acid Quantitation /Detection, Nucleic Acid Sequence, Nucleotide, Performance, Play, Pyrophosphate, Role, Sectioning, University, Visible Light